Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.056 | 0.05 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.06 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |